Bjarne Carsten Pedersen

Bjarne Carsten Pedersen
Chief Executive Officer

Bjarne (1956) has almost 30 years of experience in licensing and business operations from the European Pharma and OTC area. He started his career in Novo Nordisk, but in 1990 he joined Novartis where he worked for 17 years and became Head of Business Development and Licensing in Northern Europe. In this position Bjarne was responsible for Nicotinell®. He left Novartis in 2008 and worked as Business Development Director for Fertin Pharma until 2013 where he founded his own business providing consultancy on licensing of nicotine chewing gum worldwide. Bjarne was appointed CEO of Alkalon on 1st January 2014. Bjarne holds a M. Sc. in Pharmacy from University of Copenhagen.